May 22Alpha Tau to Present at the Jefferies Global Healthcare Conference JERUSALEM, May 21, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative...
May 21Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update- Presented preclinical data demonstrating abscopal immune effect in pancreatic murine tumor models at ESTRO 2024 Congress in Glasgow - -...
May 13Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerJERUSALEM, May 13, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative...
May 6Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow - Initial data demonstrates significant reduction in distant pancreatic cancer tumor growth rate starting from three weeks after first...
May 1Alpha Tau to Participate in May Investor ConferencesJERUSALEM, May 1, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative...